Articles Referencing SUPN

Narrower-than-Expected Loss at Supernus - Analyst Blog

5/14/2013, 10:21 am from Zacks.com in Investing, Business, Stocks

Supernus Pharmaceuticals, Inc. ( SUPN ) reported first quarter 2013 net loss per share of 60 cents, narrower than the Zacks Consensus Estimate of a loss of 63 cents and the year-ago loss... Read >>

Bearish MACD for Supernus Pharmaceuticals Inc. - Tale of the Tape

4/23/2013, 12:13 pm from Zacks.com in Investing, Investing Ideas, Stocks

Supernus Pharmaceuticals Inc. 's ( SUPN ) MACD indicator has moved into bearish territory with a reading of -0.3009. The Zacks Rank #4 ("Sell") stock decreased more than 0.19%... Read >>

Supernus Pharmaceuticals Reports Insider Buys

3/26/2013, 7:24 pm from GuruFocus in Investing

With its share prices in a downward slump, two insiders picked up nearly 40,000 shares in Supernus Pharmaceuticals ( SUPN ) this past week. The buying trend started on March 14 when... Read >>

Loss Narrows at Supernus - Analyst Blog

3/15/2013, 4:23 pm from Zacks.com in Investing, Business, Stocks

Supernus Pharmaceuticals, Inc. ( SUPN ) reported fourth quarter 2012 net loss per share of 51 cents, narrower than the Zacks Consensus Estimate of a loss of 73 cents. In the fourth quarter... Read >>

Street research for Supernus Pharmaceuticals expected on May 27

5/22/2012, 7:00 am from Renaissance Capital in News Headlines, IPOs

Street research for Supernus Pharmaceuticals, a former Shire sub developing improved drug formulations for epilepsy and ADHD, is expected to be released on 5/27/12. On 4/30/12, the... Read >>